| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
25,340,000 |
| Market
Cap: |
198.16(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$3.85 - $12.84 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 21.4 |
| Insider 3/6 Months : 22 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Pulse Biosciences is a bioelectric medicine company. The CellFX® System (CellFX) is the commercial product to harness the distinctive advantages of Co.'s proprietary Nano-Pulse Stimulation™ (NPS) technology, such as the ability to non-thermally clear cells while sparing non-cellular tissue, to treat a variety of conditions for which an optimal solution remains unfulfilled. The CellFX System is a tunable, software-enabled, console-based platform, designed to accommodate the clinical workflow preferred by physicians. Co. has also designed an integrated cloud software infrastructure called CellFX CloudConnect™. CellFX CloudConnect also facilitates direct connectivity to the CellFX System.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
1,060,434 |
11,083,371 |
11,120,651 |
| Total Buy Value |
$0 |
$9,686,016 |
$74,935,336 |
$75,020,194 |
| Total People Bought |
0 |
3 |
3 |
3 |
| Total Buy Transactions |
0 |
16 |
17 |
20 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Duggan Robert W |
Director |
– • • |
2020-12-29 |
4 |
OE |
$7.01 |
$57,580 |
I/I |
8,214 |
330,019 |
|
- |
|
| Duggan Robert W |
Director |
– • • |
2020-12-29 |
4 |
OE |
$7.01 |
$2,636,216 |
D/D |
376,065 |
11,659,781 |
|
- |
|
| Levinson Mitchell E. |
Director |
– • – |
2020-10-08 |
4 |
OE |
$7.01 |
$6,001 |
D/D |
856 |
26,569 |
|
- |
|
| Zanganeh Maky |
Director |
– • – |
2020-06-23 |
4 |
B |
$10.70 |
$12,767 |
I/I |
1,193 |
106,767 |
2.1 |
17% |
|
| Zanganeh Maky |
Director |
– • – |
2020-06-17 |
4 |
B |
$7.01 |
$55,730 |
I/I |
7,950 |
105,574 |
2.1 |
26% |
|
| Duggan Robert W |
Director |
– • • |
2020-06-15 |
4 |
OE |
$7.01 |
$383,875 |
I/I |
54,761 |
321,805 |
|
- |
|
| Duggan Robert W |
Director |
– • • |
2020-06-15 |
4 |
OE |
$7.01 |
$17,574,855 |
D/D |
2,507,112 |
11,283,716 |
|
- |
|
| Uecker Darrin |
CEO and President |
• • – |
2020-06-15 |
4 |
OE |
$7.01 |
$60,027 |
D/D |
8,563 |
126,609 |
|
- |
|
| Levinson Mitchell E. |
Director |
– • – |
2020-06-15 |
4 |
OE |
$7.01 |
$7,676 |
I/I |
1,095 |
572 |
|
- |
|
| Levinson Mitchell E. |
Director |
– • – |
2020-06-15 |
4 |
OE |
$7.01 |
$40,048 |
D/D |
5,713 |
25,713 |
|
- |
|
| Zanganeh Maky |
Director |
– • – |
2020-06-15 |
4 |
OE |
$7.01 |
$14,371 |
I/I |
2,050 |
97,624 |
|
- |
|
| Zanganeh Maky |
Director |
– • – |
2020-06-15 |
4 |
OE |
$7.01 |
$140,200 |
D/D |
20,000 |
352,500 |
|
- |
|
| Uecker Darrin |
CEO and President |
• • – |
2019-06-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(36,321) |
118,046 |
|
- |
|
| Ebbers Ed |
EVP & GM, Dermatology |
• – – |
2019-06-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,671) |
37,932 |
|
- |
|
| Levinson Mitchell E. |
Director |
– • – |
2019-03-18 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
3,835 |
|
- |
|
| Levinson Mitchell E. |
Director |
– • – |
2019-03-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
20,000 |
|
- |
|
| Duggan Robert W |
Director |
– • • |
2018-12-13 |
4 |
OE |
$12.57 |
$2,915,818 |
I/I |
232,044 |
267,044 |
|
- |
|
| Duggan Robert W |
Director |
– • • |
2018-12-13 |
4 |
OE |
$12.57 |
$36,619,028 |
D/D |
2,914,182 |
8,776,604 |
|
- |
|
| Uecker Darrin |
CEO and President |
• • – |
2018-06-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,168) |
153,981 |
|
- |
|
| Duggan Robert W |
Director |
– • • |
2018-05-11 |
4 |
B |
$23.16 |
$494,535 |
D/D |
21,353 |
5,862,422 |
3.92 |
- |
|
| Zanganeh Maky |
Director |
– • – |
2017-12-13 |
4 |
B |
$23.98 |
$26,378 |
I/I |
1,100 |
95,574 |
2.1 |
- |
|
| Duggan Robert W |
Director |
– • • |
2017-12-13 |
4 |
B |
$22.44 |
$461,277 |
D/D |
20,556 |
5,841,069 |
3.92 |
- |
|
| Zanganeh Maky |
Director |
– • – |
2017-12-12 |
4 |
B |
$23.98 |
$23,979 |
I/I |
1,000 |
94,474 |
2.1 |
- |
|
| Zanganeh Maky |
Director |
– • – |
2017-12-11 |
4 |
B |
$22.76 |
$68,289 |
I/I |
3,000 |
93,474 |
2.1 |
- |
|
| Duggan Robert W |
10% Owner |
– – • |
2017-10-19 |
4 |
B |
$22.79 |
$521,868 |
D/D |
22,901 |
5,820,513 |
2.45 |
- |
|
128 Records found
|
|
Page 3 of 6 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.23 (2.86%) 
